NFKB1 and colorectal carcinoma: Aspirin, a potent inhibitor of platelet function, has been suggested to potentially enhance the sensitivity to 5-Fu-based chemotherapy in colorectal cancer (CRC) via abrogating the activation of NF-κB both in vivo and in vitro (Fu et al., 2019).